Kaleido Biosciences Inc (KLDO)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Daniel L. Menichella
Employees:
80
18 CROSBY DRIVE, BEDFORD, MA 01730
617-674-9000

Kaleido Biosciences, Inc. develops microbiome metabolic therapies. Company develops KB195 for the treatment of patients with urea cycle disorder. KB295 to treat ulcerative colitis; KB174 to treat hepatic encephalopathy; KB109 to treat COVID-19 disease.

Data derived from most recent annual or quarterly report
Market Cap 12.361 Million Shares Outstanding42.623 Million Avg 30-day Volume 15.171 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-2.16
Price to Revenue92.2717 Debt to Equity2.0453 EBITDA-84.749 Million
Price to Book Value9.6038 Operating Margin-7940.8514 Enterprise Value85.088 Million
Current Ratio1.426 EPS Growth0.115 Quick Ratio1.296
1 Yr BETA 1.7967 52-week High/Low 9.47 / 0.15 Profit Margin-8178.2609
Operating Cash Flow Growth-25.3194 Altman Z-Score-14.0865 Free Cash Flow to Firm -59.911 Million

Are you looking for this stock instead?

View SEC Filings from KLDO instead.

View recent insider trading info

Kaleido Biosciences Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding KLDO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KLDO

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-03-02 by VAN HYLCKAMA VLIEG JOHAN
  • 4: filed on 2022-03-02 by KORN JERALD
  • 4: filed on 2022-01-18 by VAN HYLCKAMA VLIEG JOHAN
  • 4: filed on 2022-01-18 by LONG ALISON S
  • 4: filed on 2022-01-18 by KORN JERALD
  • 4: filed on 2022-01-18 by DUKE WILLIAM E.
  • 4: filed on 2022-01-18 by MENICHELLA DANIEL L
  • 4: filed on 2021-12-16 by LONG ALISON S
  • 3: filed on 2021-12-16 by LONG ALISON S
  • 4: filed on 2021-09-02 by VAN HYLCKAMA VLIEG JOHAN

    • Events (8k)

  • 8-K: filed on 2022-04-08:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-17:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-09:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-11-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-05:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-09-03:
    Item 8.01: Other Events
  • 8-K: filed on 2021-08-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-09:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-07-02:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-06-17:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    KORN JERALD COO & GENERAL COUNSEL

    • Officer
    		 4,517 2022-02-28 0

    VAN HYLCKAMA VLIEG JOHAN CHIEF SCIENTIFIC OFFICER

    • Officer
    		 4,620 2022-02-28 0

    MENICHELLA DANIEL L CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 320,200 2022-01-14 0

    DUKE WILLIAM E. CHIEF FINANCIAL OFFICER

    • Officer
    		 169,990 2022-01-14 0

    LONG ALISON S CHIEF MEDICAL OFFICER

    • Officer
    		 171,800 2022-01-14 0

    MELAS KYRIAZI THEO

    • Director
    		 15,000 2021-06-30 0

    BONNEY MICHAEL W

    • Director
    		 30,000 2021-06-30 0

    QUINN ANTHONY G.

    • Director
    		 15,000 2021-06-30 0

    MIXER JEAN K

    • Director
    		 15,000 2021-06-30 0

    BASSLER BONNIE L

    • Director
    		 15,000 2021-06-30 0

    BURNETT GRADY

    • Director
    		 15,000 2021-06-30 0

    VON MALTZAHN GEOFFREY

    • Director
    		 15,000 2021-06-30 0

    PRENER ANNE

    • Director
    		 15,000 2021-06-30 0

    FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND IV, L.P.

    FLAGSHIP VENTURES OPPORTUNITIES FUND I GENERAL PARTNER LLC

    FLAGSHIP VENTURES OPPORTUNITIES FUND I, L.P.

    NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC

    NUTRITIONAL HEALTH LTP FUND, L.P.

    AFEYAN NOUBAR

    • 10% Owner
    		 19,575,710 2021-02-08 0

    KNOBIL KATHARINE CHIEF MEDICAL OFFICER

    • Officer
    		 0 2020-10-15 0

    FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND IV, L.P.

    FLAGSHIP VENTURES OPPORTUNITIES FUND I GENERAL PARTNER LLC

    FLAGSHIP VENTURES OPPORTUNITIES FUND I, L.P.

    AFEYAN NOUBAR

    • 10% Owner
    		 19,360,710 2020-06-04 0

    NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC

    NUTRITIONAL HEALTH LTP FUND, L.P.

    • 10% Owner
    		 666,666 2020-06-04 0

    LAWTON ALISON FRANCES SEE REMARKS

    • Officer
    • Director
    		 0 2020-04-15 0

    SCALZO RICHARD WILLIAM PRINCIPAL ACCOUNTING OFFICER

    • Officer
    		 0 2019-10-11 0

    FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND V, L.P.

    FLAGSHIP VENTURELABS V LLC

    FLAGSHIP VENTURELABS V MANAGER LLC

    FLAGSHIP PIONEERING INC.

    NUTRITIONAL HEALTH DISRUPTIVE INNOVATION FUND, L.P.

    NUTRITIONAL HEALTH SIDE FUND, L.P.

    FLAGSHIP VENTURES OPPORTUNITIES FUND I, L.P.

    FLAGSHIP VENTURES OPPORTUNITIES FUND I GENERAL PARTNER LLC

    AFEYAN NOUBAR

    • Director
    • 10% Owner
    		 14,504,284 2019-03-04 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 22:15:03 UTC 1.5404 3.5296 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 21:45:05 UTC 1.5404 3.5296 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 21:15:04 UTC 1.5404 3.5296 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 20:45:04 UTC 1.5404 3.5296 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 20:15:04 UTC 1.5404 3.5296 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 19:45:04 UTC 1.5404 3.5296 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 19:15:03 UTC 1.5404 3.5296 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 18:45:04 UTC 1.5404 3.5296 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 18:15:04 UTC 1.5404 3.5296 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 17:45:04 UTC 1.5404 3.5296 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 17:15:04 UTC 1.5404 3.5296 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 16:45:04 UTC 1.5304 3.5296 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 16:15:03 UTC 1.5304 3.5296 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 15:45:04 UTC 1.5304 3.5296 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 15:15:04 UTC 1.5304 3.5296 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 14:45:04 UTC 1.5291 3.5309 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 14:15:03 UTC 1.5291 3.5309 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 13:45:03 UTC 1.5291 3.5309 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 13:15:03 UTC 1.5291 3.5309 85000
    KALEIDO BIOSCIENCES INC KLDO 2023-06-06 12:45:05 UTC 1.5291 3.5309 85000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments